Vertex Pharmaceuticals paused a Type 1 diabetes drug trial after two patients died. The drugmaker said the deaths are unrelated to the therapy and that it is waiting on independent review before restarting the study. 

New research points to a challenge patients may face once they stop taking a GLP-1 medication: The number of calories they consume may rise. 

The FDA is looking into 22 reports of patients contracting blood cancer after receiving CAR-T therapy treatment. The move comes after the agency reported initial investigation efforts into cases in November. 

Leiters Health has recalled 33 lots of IV bags filled with vancomycin, phenylephrine and fentanyl because the solutions might contain double the amount labeled. 

Merck is acquiring South San Francisco-based Harpoon Therapeutics, an oncology drugmaker, for approximately $680 million.

Lindsey Amerine, PharmD, was named chief pharmacy officer of Cleveland Clinic, effective Feb. 26. 

Johnson & Johnson plans to acquire Ambrx, a clinical-stage biotechnology company developing cancer treatments, for $1.9 billion. 

Eli Lilly's recent launch of a direct-to-consumer prescription drug website isn't expected to overthrow the pharmaceutical supply chain, but competitors are likely to take inspiration, CNBC reported Jan. 5. 

Sen. Bernie Sanders, I-Vt., and three other legislators on the Health, Education, Labor and Pensions Committee launched an investigation into inhalers, calling the prices "outrageous."

Hospital pharmacies are criticizing Florida's plan to import drugs from Canada, arguing the idea undermines the pharmacist-patient relationship and fails to be a "real solution."